Clinical Trials Browser

Phase 1 × pertuzumab × Thoracic × Clear all

NCT02507375 2015-10-16

A Study of Pertuzumab With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 1 Completed

17 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung